← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2014Last known activity
Feb 25, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05169008CollaboratorPhase 3Feb 25, 2022
- NCT05124561CollaboratorPhase 3Dec 15, 2021
- NCT04840992CollaboratorPhase 1/Phase 2Apr 20, 2021
- NCT04566770CollaboratorPhase 2Sep 24, 2020
- NCT04526990CollaboratorPhase 3Sep 15, 2020
- NCT04398147CollaboratorPhase 1/Phase 2May 31, 2020
- NCT02575456CollaboratorPhase 2Oct 1, 2015
- NCT02533791CollaboratorPhase 1Jul 1, 2015
- NCT02326194CollaboratorPhase 1Dec 1, 2014
Details
- Last known activity
- Feb 25, 2022